FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387376978> ?p ?o ?g. }

• W4387376978 endingPage "1627" @default.
• W4387376978 startingPage "1616" @default.
• W4387376978 abstract "At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic germline genetic variant (hereditary cancer syndrome—HCS). These individuals are burdened with lifelong surveillance monitoring organs for a wide spectrum of cancers. This is associated with substantial uncertainty and anxiety in the time between screening tests and while the individuals are awaiting results. Cell-free DNA (cfDNA) sequencing has recently shown potential as a non-invasive strategy for monitoring cancer. There is an opportunity for high-yield cancer early detection in HCS. To assess clinical validity of cfDNA in individuals with HCS, representatives from eight genetics centers from across Canada founded the CHARM (cfDNA in Hereditary and High-Risk Malignancies) Consortium in 2017. In this perspective, we discuss operationalization of this consortium and early data emerging from the most common and well-characterized HCSs: hereditary breast and ovarian cancer, Lynch syndrome, Li-Fraumeni syndrome, and Neurofibromatosis type 1. We identify opportunities for the incorporation of cfDNA sequencing into surveillance protocols; these opportunities are backed by examples of earlier cancer detection efficacy in HCSs from the CHARM Consortium. We seek to establish a paradigm shift in early cancer surveillance in individuals with HCSs, away from highly centralized, regimented medical screening visits and toward more accessible, frequent, and proactive care for these high-risk individuals." @default.
• W4387376978 created "2023-10-06" @default.
• W4387376978 creator A5000204204 @default.
• W4387376978 creator A5006954676 @default.
• W4387376978 creator A5009396846 @default.
• W4387376978 creator A5011411233 @default.
• W4387376978 creator A5012549313 @default.
• W4387376978 creator A5012568742 @default.
• W4387376978 creator A5012995919 @default.
• W4387376978 creator A5017371010 @default.
• W4387376978 creator A5019526929 @default.
• W4387376978 creator A5020408204 @default.
• W4387376978 creator A5020685516 @default.
• W4387376978 creator A5021700375 @default.
• W4387376978 creator A5024338497 @default.
• W4387376978 creator A5024943747 @default.
• W4387376978 creator A5026401287 @default.
• W4387376978 creator A5028832593 @default.
• W4387376978 creator A5030417997 @default.
• W4387376978 creator A5034684005 @default.
• W4387376978 creator A5036580368 @default.
• W4387376978 creator A5038154364 @default.
• W4387376978 creator A5039273020 @default.
• W4387376978 creator A5040964442 @default.
• W4387376978 creator A5041084323 @default.
• W4387376978 creator A5043733417 @default.
• W4387376978 creator A5049752286 @default.
• W4387376978 creator A5050197783 @default.
• W4387376978 creator A5052864271 @default.
• W4387376978 creator A5052896359 @default.
• W4387376978 creator A5055526329 @default.
• W4387376978 creator A5057806953 @default.
• W4387376978 creator A5058273098 @default.
• W4387376978 creator A5058511034 @default.
• W4387376978 creator A5059487848 @default.
• W4387376978 creator A5059903875 @default.
• W4387376978 creator A5060763747 @default.
• W4387376978 creator A5062030678 @default.
• W4387376978 creator A5065063060 @default.
• W4387376978 creator A5067581424 @default.
• W4387376978 creator A5069049987 @default.
• W4387376978 creator A5069103193 @default.
• W4387376978 creator A5069614140 @default.
• W4387376978 creator A5070891561 @default.
• W4387376978 creator A5071421450 @default.
• W4387376978 creator A5072207500 @default.
• W4387376978 creator A5074409475 @default.
• W4387376978 creator A5075288410 @default.
• W4387376978 creator A5077106617 @default.
• W4387376978 creator A5077588128 @default.
• W4387376978 creator A5077898047 @default.
• W4387376978 creator A5079656701 @default.
• W4387376978 creator A5082307260 @default.
• W4387376978 creator A5083128370 @default.
• W4387376978 creator A5083398439 @default.
• W4387376978 creator A5083812935 @default.
• W4387376978 creator A5084408964 @default.
• W4387376978 creator A5085688755 @default.
• W4387376978 creator A5091699198 @default.
• W4387376978 creator A5093010811 @default.
• W4387376978 creator A5093010812 @default.
• W4387376978 date "2023-10-01" @default.
• W4387376978 modified "2023-10-17" @default.
• W4387376978 title "Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy" @default.
• W4387376978 cites W1940241680 @default.
• W4387376978 cites W1968585700 @default.
• W4387376978 cites W1977610165 @default.
• W4387376978 cites W2011830133 @default.
• W4387376978 cites W2012095386 @default.
• W4387376978 cites W2021343669 @default.
• W4387376978 cites W2031448889 @default.
• W4387376978 cites W2034726113 @default.
• W4387376978 cites W2037737757 @default.
• W4387376978 cites W2094248942 @default.
• W4387376978 cites W2095741303 @default.
• W4387376978 cites W2095770043 @default.
• W4387376978 cites W2095909899 @default.
• W4387376978 cites W2104524209 @default.
• W4387376978 cites W2125556118 @default.
• W4387376978 cites W2134026526 @default.
• W4387376978 cites W2147221503 @default.
• W4387376978 cites W2150962472 @default.
• W4387376978 cites W2165854883 @default.
• W4387376978 cites W2172296348 @default.
• W4387376978 cites W2216474103 @default.
• W4387376978 cites W2238955528 @default.
• W4387376978 cites W2239118478 @default.
• W4387376978 cites W2269179103 @default.
• W4387376978 cites W2291991964 @default.
• W4387376978 cites W2344497321 @default.
• W4387376978 cites W2346711478 @default.
• W4387376978 cites W2402146695 @default.
• W4387376978 cites W2420120068 @default.
• W4387376978 cites W2480841917 @default.
• W4387376978 cites W2507995480 @default.
• W4387376978 cites W2606403603 @default.
• W4387376978 cites W2620901258 @default.
• W4387376978 cites W2625944954 @default.

• next